Detalhe da pesquisa
1.
Palliative Care Utilisation and Outcomes in Patients Admitted for Heart Failure in a Victorian Healthcare Service.
Heart Lung Circ
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461106
2.
Characterization of the ATP4 ion pump in Toxoplasma gondii.
J Biol Chem
; 294(14): 5720-5734, 2019 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723156
3.
The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic Screens.
PLoS Pathog
; 13(2): e1006180, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28178359
4.
Cell Swelling Induced by the Antimalarial KAE609 (Cipargamin) and Other PfATP4-Associated Antimalarials.
Antimicrob Agents Chemother
; 62(6)2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29555632
5.
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.
Proc Natl Acad Sci U S A
; 111(50): E5455-62, 2014 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453091
6.
A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargamin.
Nat Commun
; 13(1): 5746, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180431
7.
Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis.
Sci Rep
; 8(1): 8795, 2018 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29892073
8.
Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane Disruption.
Cell Chem Biol
; 25(9): 1140-1150.e5, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30033131
9.
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles.
ACS Cent Sci
; 2(10): 687-701, 2016 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27800551